2018-2023 Global Low Molecular Weight Heparin Consumption Market Report

June 2018 | 134 pages | ID: 2F3B1B16881EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Low Molecular Weight Heparin market for 2018-2023.

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.
Over the next five years, LPI(LP Information) projects that Low Molecular Weight Heparin will register a 5.6% CAGR in terms of revenue, reach US$ 380 million by 2023, from US$ 270 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Low Molecular Weight Heparin market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Enoxaparin
• Dalteparin
• Tinzaparin
• Fraxiparine

Segmentation by application:

• Treatment of Venous Thromboembolism
• Complications of Pregnancy
• Cardioversion of Atrial Fibrillation/Flutter
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Aspen
• Sanofi-aventis
• Pfizer
• Opocrin
• CSBIO
• Dongying Tiandong Pharmaceutical
• Changzhou Qianhong Bio-pharma
• Techdow
• Yantai Dongcheng Pharmaceutical Group

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Low Molecular Weight Heparin consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Low Molecular Weight Heparin market by identifying its various subsegments.
• Focuses on the key global Low Molecular Weight Heparin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Low Molecular Weight Heparin with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Low Molecular Weight Heparin submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Low Molecular Weight Heparin Consumption 2013-2023
  2.1.2 Low Molecular Weight Heparin Consumption CAGR by Region
2.2 Low Molecular Weight Heparin Segment by Type
  2.2.1 Enoxaparin
  2.2.2 Dalteparin
  2.2.3 Tinzaparin
  2.2.4 Fraxiparine
2.3 Low Molecular Weight Heparin Consumption by Type
  2.3.1 Global Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
  2.3.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Low Molecular Weight Heparin Sale Price by Type (2013-2018)
2.4 Low Molecular Weight Heparin Segment by Application
  2.4.1 Treatment of Venous Thromboembolism
  2.4.2 Complications of Pregnancy
  2.4.3 Cardioversion of Atrial Fibrillation/Flutter
  2.4.4 Others
2.5 Low Molecular Weight Heparin Consumption by Application
  2.5.1 Global Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
  2.5.2 Global Low Molecular Weight Heparin Value and Market Share by Application (2013-2018)
  2.5.3 Global Low Molecular Weight Heparin Sale Price by Application (2013-2018)

3 GLOBAL LOW MOLECULAR WEIGHT HEPARIN BY PLAYERS

3.1 Global Low Molecular Weight Heparin Sales Market Share by Players
  3.1.1 Global Low Molecular Weight Heparin Sales by Players (2016-2018)
  3.1.2 Global Low Molecular Weight Heparin Sales Market Share by Players (2016-2018)
3.2 Global Low Molecular Weight Heparin Revenue Market Share by Players
  3.2.1 Global Low Molecular Weight Heparin Revenue by Players (2016-2018)
  3.2.2 Global Low Molecular Weight Heparin Revenue Market Share by Players (2016-2018)
3.3 Global Low Molecular Weight Heparin Sale Price by Players
3.4 Global Low Molecular Weight Heparin Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Low Molecular Weight Heparin Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Low Molecular Weight Heparin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 LOW MOLECULAR WEIGHT HEPARIN BY REGIONS

4.1 Low Molecular Weight Heparin by Regions
  4.1.1 Global Low Molecular Weight Heparin Consumption by Regions
  4.1.2 Global Low Molecular Weight Heparin Value by Regions
4.2 Americas Low Molecular Weight Heparin Consumption Growth
4.3 APAC Low Molecular Weight Heparin Consumption Growth
4.4 Europe Low Molecular Weight Heparin Consumption Growth
4.5 Middle East & Africa Low Molecular Weight Heparin Consumption Growth

5 AMERICAS

5.1 Americas Low Molecular Weight Heparin Consumption by Countries
  5.1.1 Americas Low Molecular Weight Heparin Consumption by Countries (2013-2018)
  5.1.2 Americas Low Molecular Weight Heparin Value by Countries (2013-2018)
5.2 Americas Low Molecular Weight Heparin Consumption by Type
5.3 Americas Low Molecular Weight Heparin Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Low Molecular Weight Heparin Consumption by Countries
  6.1.1 APAC Low Molecular Weight Heparin Consumption by Countries (2013-2018)
  6.1.2 APAC Low Molecular Weight Heparin Value by Countries (2013-2018)
6.2 APAC Low Molecular Weight Heparin Consumption by Type
6.3 APAC Low Molecular Weight Heparin Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Low Molecular Weight Heparin by Countries
  7.1.1 Europe Low Molecular Weight Heparin Consumption by Countries (2013-2018)
  7.1.2 Europe Low Molecular Weight Heparin Value by Countries (2013-2018)
7.2 Europe Low Molecular Weight Heparin Consumption by Type
7.3 Europe Low Molecular Weight Heparin Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Low Molecular Weight Heparin by Countries
  8.1.1 Middle East & Africa Low Molecular Weight Heparin Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Low Molecular Weight Heparin Value by Countries (2013-2018)
8.2 Middle East & Africa Low Molecular Weight Heparin Consumption by Type
8.3 Middle East & Africa Low Molecular Weight Heparin Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Low Molecular Weight Heparin Distributors
10.3 Low Molecular Weight Heparin Customer

11 GLOBAL LOW MOLECULAR WEIGHT HEPARIN MARKET FORECAST

11.1 Global Low Molecular Weight Heparin Consumption Forecast (2018-2023)
11.2 Global Low Molecular Weight Heparin Forecast by Regions
  11.2.1 Global Low Molecular Weight Heparin Forecast by Regions (2018-2023)
  11.2.2 Global Low Molecular Weight Heparin Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Low Molecular Weight Heparin Forecast by Type
11.8 Global Low Molecular Weight Heparin Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Aspen
  12.1.1 Company Details
  12.1.2 Low Molecular Weight Heparin Product Offered
  12.1.3 Aspen Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Aspen News
12.2 Sanofi-aventis
  12.2.1 Company Details
  12.2.2 Low Molecular Weight Heparin Product Offered
  12.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Sanofi-aventis News
12.3 Pfizer
  12.3.1 Company Details
  12.3.2 Low Molecular Weight Heparin Product Offered
  12.3.3 Pfizer Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pfizer News
12.4 Opocrin
  12.4.1 Company Details
  12.4.2 Low Molecular Weight Heparin Product Offered
  12.4.3 Opocrin Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Opocrin News
12.5 CSBIO
  12.5.1 Company Details
  12.5.2 Low Molecular Weight Heparin Product Offered
  12.5.3 CSBIO Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 CSBIO News
12.6 Dongying Tiandong Pharmaceutical
  12.6.1 Company Details
  12.6.2 Low Molecular Weight Heparin Product Offered
  12.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Dongying Tiandong Pharmaceutical News
12.7 Changzhou Qianhong Bio-pharma
  12.7.1 Company Details
  12.7.2 Low Molecular Weight Heparin Product Offered
  12.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Changzhou Qianhong Bio-pharma News
12.8 Techdow
  12.8.1 Company Details
  12.8.2 Low Molecular Weight Heparin Product Offered
  12.8.3 Techdow Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Techdow News
12.9 Yantai Dongcheng Pharmaceutical Group
  12.9.1 Company Details
  12.9.2 Low Molecular Weight Heparin Product Offered
  12.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Yantai Dongcheng Pharmaceutical Group News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Low Molecular Weight Heparin
Table Product Specifications of Low Molecular Weight Heparin
Figure Low Molecular Weight Heparin Report Years Considered
Figure Market Research Methodology
Figure Global Low Molecular Weight Heparin Consumption Growth Rate 2013-2023 (MT)
Figure Global Low Molecular Weight Heparin Value Growth Rate 2013-2023 ($ Millions)
Table Low Molecular Weight Heparin Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Enoxaparin
Table Major Players of Enoxaparin
Figure Product Picture of Dalteparin
Table Major Players of Dalteparin
Figure Product Picture of Tinzaparin
Table Major Players of Tinzaparin
Figure Product Picture of Fraxiparine
Table Major Players of Fraxiparine
Table Global Consumption Sales by Type (2013-2018)
Table Global Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
Figure Global Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
Table Global Low Molecular Weight Heparin Revenue by Type (2013-2018) ($ million)
Table Global Low Molecular Weight Heparin Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Low Molecular Weight Heparin Value Market Share by Type (2013-2018)
Table Global Low Molecular Weight Heparin Sale Price by Type (2013-2018)
Figure Low Molecular Weight Heparin Consumed in Treatment of Venous Thromboembolism
Figure Global Low Molecular Weight Heparin Market: Treatment of Venous Thromboembolism (2013-2018) (MT)
Figure Global Low Molecular Weight Heparin Market: Treatment of Venous Thromboembolism (2013-2018) ($ Millions)
Figure Global Treatment of Venous Thromboembolism YoY Growth ($ Millions)
Figure Low Molecular Weight Heparin Consumed in Complications of Pregnancy
Figure Global Low Molecular Weight Heparin Market: Complications of Pregnancy (2013-2018) (MT)
Figure Global Low Molecular Weight Heparin Market: Complications of Pregnancy (2013-2018) ($ Millions)
Figure Global Complications of Pregnancy YoY Growth ($ Millions)
Figure Low Molecular Weight Heparin Consumed in Cardioversion of Atrial Fibrillation/Flutter
Figure Global Low Molecular Weight Heparin Market: Cardioversion of Atrial Fibrillation/Flutter (2013-2018) (MT)
Figure Global Low Molecular Weight Heparin Market: Cardioversion of Atrial Fibrillation/Flutter (2013-2018) ($ Millions)
Figure Global Cardioversion of Atrial Fibrillation/Flutter YoY Growth ($ Millions)
Figure Low Molecular Weight Heparin Consumed in Others
Figure Global Low Molecular Weight Heparin Market: Others (2013-2018) (MT)
Figure Global Low Molecular Weight Heparin Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
Figure Global Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
Table Global Low Molecular Weight Heparin Value by Application (2013-2018)
Table Global Low Molecular Weight Heparin Value Market Share by Application (2013-2018)
Figure Global Low Molecular Weight Heparin Value Market Share by Application (2013-2018)
Table Global Low Molecular Weight Heparin Sale Price by Application (2013-2018)
Table Global Low Molecular Weight Heparin Sales by Players (2016-2018) (MT)
Table Global Low Molecular Weight Heparin Sales Market Share by Players (2016-2018)
Figure Global Low Molecular Weight Heparin Sales Market Share by Players in 2016
Figure Global Low Molecular Weight Heparin Sales Market Share by Players in 2017
Table Global Low Molecular Weight Heparin Revenue by Players (2016-2018) ($ Millions)
Table Global Low Molecular Weight Heparin Revenue Market Share by Players (2016-2018)
Figure Global Low Molecular Weight Heparin Revenue Market Share by Players in 2016
Figure Global Low Molecular Weight Heparin Revenue Market Share by Players in 2017
Table Global Low Molecular Weight Heparin Sale Price by Players (2016-2018)
Figure Global Low Molecular Weight Heparin Sale Price by Players in 2017
Table Global Low Molecular Weight Heparin Manufacturing Base Distribution and Sales Area by Players
Table Players Low Molecular Weight Heparin Products Offered
Table Low Molecular Weight Heparin Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Low Molecular Weight Heparin Consumption by Regions 2013-2018 (MT)
Table Global Low Molecular Weight Heparin Consumption Market Share by Regions 2013-2018
Figure Global Low Molecular Weight Heparin Consumption Market Share by Regions 2013-2018
Table Global Low Molecular Weight Heparin Value by Regions 2013-2018 ($ Millions)
Table Global Low Molecular Weight Heparin Value Market Share by Regions 2013-2018
Figure Global Low Molecular Weight Heparin Value Market Share by Regions 2013-2018
Figure Americas Low Molecular Weight Heparin Consumption 2013-2018 (MT)
Figure Americas Low Molecular Weight Heparin Value 2013-2018 ($ Millions)
Figure APAC Low Molecular Weight Heparin Consumption 2013-2018 (MT)
Figure APAC Low Molecular Weight Heparin Value 2013-2018 ($ Millions)
Figure Europe Low Molecular Weight Heparin Consumption 2013-2018 (MT)
Figure Europe Low Molecular Weight Heparin Value 2013-2018 ($ Millions)
Figure Middle East & Africa Low Molecular Weight Heparin Consumption 2013-2018 (MT)
Figure Middle East & Africa Low Molecular Weight Heparin Value 2013-2018 ($ Millions)
Table Americas Low Molecular Weight Heparin Consumption by Countries (2013-2018) (MT)
Table Americas Low Molecular Weight Heparin Consumption Market Share by Countries (2013-2018)
Figure Americas Low Molecular Weight Heparin Consumption Market Share by Countries in 2017
Table Americas Low Molecular Weight Heparin Value by Countries (2013-2018) ($ Millions)
Table Americas Low Molecular Weight Heparin Value Market Share by Countries (2013-2018)
Figure Americas Low Molecular Weight Heparin Value Market Share by Countries in 2017
Table Americas Low Molecular Weight Heparin Consumption by Type (2013-2018) (MT)
Table Americas Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
Figure Americas Low Molecular Weight Heparin Consumption Market Share by Type in 2017
Table Americas Low Molecular Weight Heparin Consumption by Application (2013-2018) (MT)
Table Americas Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
Figure Americas Low Molecular Weight Heparin Consumption Market Share by Application in 2017
Figure United States Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure United States Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Canada Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Canada Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Mexico Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Mexico Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Table APAC Low Molecular Weight Heparin Consumption by Countries (2013-2018) (MT)
Table APAC Low Molecular Weight Heparin Consumption Market Share by Countries (2013-2018)
Figure APAC Low Molecular Weight Heparin Consumption Market Share by Countries in 2017
Table APAC Low Molecular Weight Heparin Value by Countries (2013-2018) ($ Millions)
Table APAC Low Molecular Weight Heparin Value Market Share by Countries (2013-2018)
Figure APAC Low Molecular Weight Heparin Value Market Share by Countries in 2017
Table APAC Low Molecular Weight Heparin Consumption by Type (2013-2018) (MT)
Table APAC Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
Figure APAC Low Molecular Weight Heparin Consumption Market Share by Type in 2017
Table APAC Low Molecular Weight Heparin Consumption by Application (2013-2018) (MT)
Table APAC Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
Figure APAC Low Molecular Weight Heparin Consumption Market Share by Application in 2017
Figure China Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure China Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Japan Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Japan Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Korea Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Korea Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Southeast Asia Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure India Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure India Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Australia Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Australia Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Table Europe Low Molecular Weight Heparin Consumption by Countries (2013-2018) (MT)
Table Europe Low Molecular Weight Heparin Consumption Market Share by Countries (2013-2018)
Figure Europe Low Molecular Weight Heparin Consumption Market Share by Countries in 2017
Table Europe Low Molecular Weight Heparin Value by Countries (2013-2018) ($ Millions)
Table Europe Low Molecular Weight Heparin Value Market Share by Countries (2013-2018)
Figure Europe Low Molecular Weight Heparin Value Market Share by Countries in 2017
Table Europe Low Molecular Weight Heparin Consumption by Type (2013-2018) (MT)
Table Europe Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
Figure Europe Low Molecular Weight Heparin Consumption Market Share by Type in 2017
Table Europe Low Molecular Weight Heparin Consumption by Application (2013-2018) (MT)
Table Europe Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
Figure Europe Low Molecular Weight Heparin Consumption Market Share by Application in 2017
Figure Germany Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Germany Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure France Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure France Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure UK Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure UK Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Italy Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Italy Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Russia Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Russia Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Spain Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Spain Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Low Molecular Weight Heparin Consumption by Countries (2013-2018) (MT)
Table Middle East & Africa Low Molecular Weight Heparin Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Low Molecular Weight Heparin Consumption Market Share by Countries in 2017
Table Middle East & Africa Low Molecular Weight Heparin Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Low Molecular Weight Heparin Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Low Molecular Weight Heparin Value Market Share by Countries in 2017
Table Middle East & Africa Low Molecular Weight Heparin Consumption by Type (2013-2018) (MT)
Table Middle East & Africa Low Molecular Weight Heparin Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Low Molecular Weight Heparin Consumption Market Share by Type in 2017
Table Middle East & Africa Low Molecular Weight Heparin Consumption by Application (2013-2018) (MT)
Table Middle East & Africa Low Molecular Weight Heparin Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Low Molecular Weight Heparin Consumption Market Share by Application in 2017
Figure Egypt Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Egypt Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure South Africa Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure South Africa Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Israel Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Israel Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure Turkey Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure Turkey Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Low Molecular Weight Heparin Consumption Growth 2013-2018 (MT)
Figure GCC Countries Low Molecular Weight Heparin Value Growth 2013-2018 ($ Millions)
Table Low Molecular Weight Heparin Distributors List
Table Low Molecular Weight Heparin Customer List
Figure Global Low Molecular Weight Heparin Consumption Growth Rate Forecast (2018-2023) (MT)
Figure Global Low Molecular Weight Heparin Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Low Molecular Weight Heparin Consumption Forecast by Countries (2018-2023) (MT)
Table Global Low Molecular Weight Heparin Consumption Market Forecast by Regions
Table Global Low Molecular Weight Heparin Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Low Molecular Weight Heparin Value Market Share Forecast by Regions
Figure Americas Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Americas Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure APAC Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure APAC Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Europe Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Europe Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Middle East & Africa Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Middle East & Africa Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure United States Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure United States Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Canada Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Canada Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Mexico Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Mexico Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Brazil Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Brazil Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure China Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure China Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Japan Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Japan Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Korea Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Korea Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Southeast Asia Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Southeast Asia Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure India Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure India Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Australia Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Australia Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Germany Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Germany Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure France Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure France Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure UK Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure UK Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Italy Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Italy Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Russia Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Russia Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Spain Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Spain Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Egypt Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Egypt Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure South Africa Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure South Africa Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Israel Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Israel Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure Turkey Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure Turkey Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Figure GCC Countries Low Molecular Weight Heparin Consumption 2018-2023 (MT)
Figure GCC Countries Low Molecular Weight Heparin Value 2018-2023 ($ Millions)
Table Global Low Molecular Weight Heparin Consumption Forecast by Type (2018-2023) (MT)
Table Global Low Molecular Weight Heparin Consumption Market Share Forecast by Type (2018-2023)
Table Global Low Molecular Weight Heparin Value Forecast by Type (2018-2023) ($ Millions)
Table Global Low Molecular Weight Heparin Value Market Share Forecast by Type (2018-2023)
Table Global Low Molecular Weight Heparin Consumption Forecast by Application (2018-2023) (MT)
Table Global Low Molecular Weight Heparin Consumption Market Share Forecast by Application (2018-2023)
Table Global Low Molecular Weight Heparin Value Forecast by Application (2018-2023) ($ Millions)
Table Global Low Molecular Weight Heparin Value Market Share Forecast by Application (2018-2023)
Table Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Aspen Low Molecular Weight Heparin Market Share (2016-2018)
Table Sanofi-aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-aventis Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi-aventis Low Molecular Weight Heparin Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Low Molecular Weight Heparin Market Share (2016-2018)
Table Opocrin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Opocrin Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Opocrin Low Molecular Weight Heparin Market Share (2016-2018)
Table CSBIO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSBIO Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSBIO Low Molecular Weight Heparin Market Share (2016-2018)
Table Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Market Share (2016-2018)
Table Changzhou Qianhong Bio-pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Market Share (2016-2018)
Table Techdow Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Techdow Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Techdow Low Molecular Weight Heparin Market Share (2016-2018)
Table Yantai Dongcheng Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Market Share (2016-2018)